Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000037524 | SCV000061182 | benign | not specified | 2011-09-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000037524 | SCV000308987 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000253927 | SCV000317540 | benign | Cardiovascular phenotype | 2015-06-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001513923 | SCV001721629 | benign | Hypertrophic cardiomyopathy 14 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001610328 | SCV001833978 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000037524 | SCV001925605 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000037524 | SCV001954280 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000037524 | SCV001973891 | benign | not specified | no assertion criteria provided | clinical testing |